Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 561 results for "pharma"

Sell Bharti Infratel, TCS; buy Dishman Pharma: Ashwani Gujral

Ashwani Gujral of ashwanigujral.com is of the view that one may sell Bharti Infratel and Tata Consultancy Services. Money Control, 2 days ago

5,666 images for pharma

Med India, 2 days ago
Money Today, 3 days ago
catchnews.com, 5 days ago
Money Today, 4 days ago
Money Control, 3 days ago
One India, 2 days ago
Sahara Samay English, 5 days ago
Business Standard, 5 days ago
One India, 2 days ago
Money Control, 5 days ago
Sify

Sensex surges over 150 points; Sun Pharma, Infosys up

Indian markets bounced back on Thursday snapping earlier losses. At 02.00 p.m, the Sensex was trading up 168.09 points or 0.60% at 28,323.65 with 22 components gaining. Meanwhile, the Nifty was trading higher by 51.20 points or 0.59% at 8,775.90 with 40 ...
 Myiris3 days ago Sensex, Nifty trade flat; Sun Pharma, Tata Motors top gainers  Myiris3 days ago Of the 30-share Sensex pack, 18 scrips ended lower while  DNA4 days ago Indian shares down; Tata Motors, Sun Pharma drag  Sify4 days ago
[x]  
Reuters

Sun Pharma Q3 net dips 5% to Rs 1,471 cr on slower sales in US

Sun also said sales in its emerging markets rose 14% and those in the rest of the world were up 33%
 Business Standard5 days ago Sun Pharma Q3 profit dips 5% to Rs 1,472 cr  Business Standard5 days ago Sun Pharma reports surprise drop in profits  Business Standard5 days ago Sun Pharma's profits drop as U.S. sales hit by pricing, supply issues  Reuters5 days ago
[x]  
Rediff.com

Sensex rebounds after 2-session fall, jumps 146 pts as IT, pharma lead recovery

Foreign portfolio investors (FPIs) bought shares worth a net Rs 225.84 crore Wednesday The post Sensex rebounds after 2-session fall, jumps 146 pts as IT, pharma lead recovery appeared first on Firstpost .
 First Post.com3 days ago Sensex rebounds 146 points as IT, pharma come good  Rediff.com3 days ago Sensex rebounds 146 pts as IT, pharma come good  Business Standard3 days ago Sensex bounces 146 pts; IT, pharma lead rally  The Financial Chronicle3 days ago
[x]  

Sensex snaps 2-day losses, Nifty ends above 8750; pharma shines

Sun Pharma, Infosys, Maruti Suzuki, Tata Steel, GAIL, Aurobindo Pharma and Tata Motors (DVR) gained 2-4 percent while ITC, LT, ICICI Bank, Asian Paints, Coal India, Bharti Infratel, Bosch and BPCL were under pressure.
 Money Control3 days ago Stocks in news: Tata Motors, DLF, Cadila, JSPL, MOIL, Intellect  Money Control4 days ago Today's picks: 14 February, 2017  Business Standard5 days ago Today's picks: 31 January, 2017  Business Standard2 weeks ago

Buy Dishman Pharma; target of Rs 285: Systematix

Systematix is bullish on Dishman Pharma has recommended buy rating on the stock with a target price of Rs 285 in its research report dated February 14, 2017.
 Money Control2 days ago Buy Aurobindo Pharma; target of Rs 965: ICICI Direct  Money Control6 days ago Buy Torrent Pharma; target of Rs 1475: ICICI Direct  Money Control1 week ago Buy Glenmark Pharma; target of Rs 1155: ICICI Direct  Money Control1 week ago
Sify

Sensex up nearly 200 points; Pharma, bank stocks shine

Key Indian stock indices Sensex and the Nifty50 remain fairly well placed in positive territory this afternoon, as buying continues at several front line counters from across various sectors. Healthcare, bank and oil stocks are among the prominent gainers. A ...
 Sify2 days ago Sensex up 114 points; IT stocks post strong gains  Sify3 days ago Sensex Opens Flat; Pharma Stocks Gain  Equitymaster.com5 days ago Opening Bell - Markets opened with negative bias taking cues from Asian markets; Sun Pharma up by 1.34%  India Infoline1 week ago
[x]  

Biocon at new high; FDA accepts BLA for biosimilar Pegfilgrastim

Biocon shares gained 2.6 percent to hit a record high of Rs 1,123 after the US health regulator USFDA has accepted pharma major Mylan's biologics licence application (BLA) for MYL-1401H, a proposed biosimilar Pegfilgrastim.
 Money Control2 days ago FDA accepts Mylan's BLA for proposed biosimilar Pegfilgrastim  DNA2 days ago
Rediff.com

IT, pharma stocks help Sensex rebound 146pts; Midcap outperforms

The broader markets outperformed benchmarks, with the BSE Midcap and Smallcap indices climbed 1.3 percent each on strong breadth. About two shares gained for every share falling on bourses.
 Money Control3 days ago Sensex pares gains to turn flat, Nifty below 8,750; Sun Pharma top gainer  Business Standard3 days ago Cipla, Glenmark & Sun Pharma contribute 60% to BSE Healthcare Index gains  India Infoline2 weeks ago Markets end flat as investors stay cautious ahead of December earnings  Rediff.com1 month ago

Sun Pharma up 3% as co may shift key products from Halol plant

Halol is an important plant for Sun Pharma and contributed 10-15 percent to its US sales before the factory received a warning letter from the US Food Drug Administration for violation of manufacturing norms in December 2015.
 Money Control3 days ago Key Sun Pharma drugs to bid Halol goodbye  Business Standard4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less